Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Dec 10, 2020 5:33pm
100 Views
Post# 32084799

RE:RE:RE:Understand what your buying & trajectory

RE:RE:RE:Understand what your buying & trajectory
wagyusteak wrote:

 

indoubtgetout wrote: What I understand is that you are completely wrong about GUD!!   GUD is a "value trap" and its only going to get worse for shareholders.   Think of it this way, why does GUD need to file a $360 million mixed security shelf offering that expires in 25 months?   It has a market cap of $700 million....yes, at some point GUD will have to raise money "to invest in the long term objective of its business"....been ten years now.   Like I have said before, GUD should be a private company then it would perform better as private shareholders would not put up with Jgoody's incompetence.   SELL, GET OUT!!   GUD IS A VALUE TRAP.......

finacing with cheap debt to either make another huge acquisition or buy back shares at large scale!!!




Ah yes, in comes the board scholar with another bright idea lol... Borrow money to buyback it;s own shares. We call this arbitrage and means this inept management is out of ideas. Moral must be at all time low at the office. They were buying at $7.50..just like you and Mugnuts lolll..Every single share purchased so far has been a LOSS to shareholders. How many millions have we lost?? One of the worst performing stocks in the country, an amazing feat to achieve in this market frenzy. Keep posting more of your excellent ideas.


<< Previous
Bullboard Posts
Next >>